Leland Shapiro

USPTO Granted Patents = 10 (Patent Applications = 12)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 1.0

ph-index = 4

Forward Citations = 104(Granted Patents)

Company Filing History:

5 out of 1,379

University of Colorado

University of Technology

patents

4. 1 out of 80

University Technology Corporation

patents

5. 1 out of 832,718

Other

patents

Years Active: 2002-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10913790 - Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules (2021-02-09),

2. 9695229 - Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules (2017-07-04),

3. 9499606 - Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules (2016-11-22),

4. 8633305 - Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules (2014-01-21),

5. 8071551 - Methods and compositions for treating diabetes (2011-12-06),

6. 7850970 - Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections (2010-12-14),

7. 7807781 - Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections (2010-10-05),

8. 7704958 - Methods and compositions for inhibiting apoptosis using serine protease inhibitors (2010-04-27),

9. 6849605 - Inhibitors of serine protease activity, methods and compositions for treatment of viral infections (2005-02-01),

10. 6489308 - Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions (2002-12-03),

Title: Leland Shapiro: Innovator in Bacterial Disease Treatment

Introduction

Leland Shapiro is a prominent inventor based in Denver, Colorado, known for his significant contributions to the field of medical research. With a total of 10 patents to his name, he has focused on developing innovative methods for treating and preventing bacterial diseases. His work has the potential to impact the medical community significantly.

Latest Patents

One of Leland Shapiro's latest patents involves compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules. This novel method aims to treat and prevent bacterial diseases, particularly focusing on the inhibition of Gram-negative, Gram-positive, and acid-fast bacilli, including tuberculosis (TB), Mycobacterium avium complex (MAC), and anthrax. The invention emphasizes the modulation of cellular activities, including macrophage activity, and introduces inhibitory compounds that comprise both naturally occurring and man-made inhibitors of serine protease.

Career Highlights

Throughout his career, Leland Shapiro has worked with notable organizations, including the University of Colorado and Bioholding, Inc. His research has been instrumental in advancing the understanding of bacterial diseases and developing effective treatment methods.

Collaborations

Leland has collaborated with esteemed colleagues such as Eli C. Lewis and Charles A. Dinarello, contributing to a rich exchange of ideas and innovations in the field.

Conclusion

Leland Shapiro's work exemplifies the spirit of innovation in medical research, particularly in the fight against bacterial diseases. His patents and collaborations highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.